Extension of Interim Stability Agreement Period Ascendis Health Limited (Registration number 2008/005856/06) (Incorporated in the Republic of South Africa) Share code: ASC ISIN: ZAE000185005 (“Ascendis Health” or “the Company”) Extension of Interim Stability Agreement Period Shareholders are referred to the announcement released by Ascendis Health on the Stock Exchange News Service of the JSE on 11 March 2020 wherein shareholders were advised that the group’s Lender Consortium agreed to further extend an Interim Stability Agreement (“ISA”) to 15 May 2020 in order to seek a more permanent structure of its existing debt facilities through its Lender Consortium. As part of the group’s intention to focus on its core operations, address its capital structure and materially deleverage its business, it is pursuing a number of divestment options. The process of negotiating re- financing terms with the Lender Consortium is in the final stages of being concluded, which also involves obtaining certain regulatory approvals. The Lender Consortium has therefore agreed to extend the ISA period to 5 June 2020. 15 May 2020 Johannesburg Sponsor Questco Corporate Advisory Proprietary Limited Date: 15-05-2020 03:50:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.